Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ucb Sa Npv (UCBJF)

Ucb Sa Npv (UCBJF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ucb Sa Npv Allee de la Recherche 60 Brussels C9 1070 BEL

www.ucb.com Employees: 9,083 P: 32-2559-9999

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease. It also provides therapy in the areas of oncology, immunology, inflammation, allergy and respiratory diseases. UCB delivers small and large molecule solutions to specialists for use in the treatment of severe diseases.

Key Statistics

Overview:

Market Capitalization, $K 34,779,680
Enterprise Value, $K 37,135,852
Shares Outstanding, K 189,020
Float, K 0
% Float 0.00%
Short Interest, K 1,132
Short Float 0.00%
Days to Cover 999.99
Short Volume Ratio 0.94
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 5,684 M
Annual Net Income, $ 371,230 K
EBIT, $ 0 K
EBITDA, $ 1,332 M

Growth:

1-Year Return 60.12%
3-Year Return 227.31%
5-Year Return 0.00%
5-Year Revenue Growth 3.91%
5-Year Earnings Growth -18.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 05/05/14
Dividend Payout Ratio 0.00%

UCBJF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 38.94
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 6.53%
Debt/Equity 0.34
Price/Sales N/A
Price/Cash Flow 23.28
Price/Book 3.64
Book Value/Share 0.00
Interest Coverage 3.10
60-Month Beta 0.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.